BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 27845767)

  • 1. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.
    Galluzzi L; Bravo-San Pedro JM; Demaria S; Formenti SC; Kroemer G
    Nat Rev Clin Oncol; 2017 Apr; 14(4):247-258. PubMed ID: 27845767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potentially conflicting cell autonomous and cell non-autonomous functions of autophagy in mediating tumor response to cancer therapy.
    Gewirtz DA; Tyutyunyk-Massey L; Landry JW
    Biochem Pharmacol; 2018 Jul; 153():46-50. PubMed ID: 29408462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.
    Li YY; Feun LG; Thongkum A; Tu CH; Chen SM; Wangpaichitr M; Wu C; Kuo MT; Savaraj N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy regulation as a promising approach for improving cancer immunotherapy.
    Ishimwe N; Zhang W; Qian J; Zhang Y; Wen L
    Cancer Lett; 2020 Apr; 475():34-42. PubMed ID: 32014460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles augment the therapeutic window of RT and immunotherapy for treating cancers: pivotal role of autophagy.
    Wu YH; Chen RJ; Chiu HW; Yang LX; Wang YL; Chen YY; Yeh YL; Liao MY; Wang YJ
    Theranostics; 2023; 13(1):40-58. PubMed ID: 36593951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy in natural and therapy-driven anticancer immunosurveillance.
    Pietrocola F; Bravo-San Pedro JM; Galluzzi L; Kroemer G
    Autophagy; 2017; 13(12):2163-2170. PubMed ID: 28598229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Challenge of Developing Autophagy Inhibition as a Therapeutic Strategy.
    Gewirtz DA
    Cancer Res; 2016 Oct; 76(19):5610-5614. PubMed ID: 27634767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy modulation: a prudent approach in cancer treatment?
    Bishop E; Bradshaw TD
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):913-922. PubMed ID: 30182146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of radiotherapy and immune checkpoint inhibitors.
    Pilones KA; Vanpouille-Box C; Demaria S
    Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy-associated immune responses and cancer immunotherapy.
    Pan H; Chen L; Xu Y; Han W; Lou F; Fei W; Liu S; Jing Z; Sui X
    Oncotarget; 2016 Apr; 7(16):21235-46. PubMed ID: 26788909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy, autophagy-associated adaptive immune responses and its role in hematologic malignancies.
    You L; Jin S; Zhu L; Qian W
    Oncotarget; 2017 Feb; 8(7):12374-12388. PubMed ID: 27902471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death.
    Martins I; Michaud M; Sukkurwala AQ; Adjemian S; Ma Y; Shen S; Kepp O; Menger L; Vacchelli E; Galluzzi L; Zitvogel L; Kroemer G
    Autophagy; 2012 Mar; 8(3):413-5. PubMed ID: 22361584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment and autophagy cross-talk: Implications in cancer therapy.
    Gomes LR; Vessoni AT; Menck CFM
    Pharmacol Res; 2016 May; 107():300-307. PubMed ID: 27037157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between autophagy and the immune system and its applications for tumor immunotherapy.
    Jiang GM; Tan Y; Wang H; Peng L; Chen HT; Meng XJ; Li LL; Liu Y; Li WF; Shan H
    Mol Cancer; 2019 Jan; 18(1):17. PubMed ID: 30678689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal partnership of radiation and immunotherapy: from preclinical studies to clinical translation.
    Demaria S; Pilones KA; Vanpouille-Box C; Golden EB; Formenti SC
    Radiat Res; 2014 Aug; 182(2):170-81. PubMed ID: 24937779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights into the Role of Autophagy in Tumor Immune Microenvironment.
    Li CJ; Liao WT; Wu MY; Chu PY
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
    Shahabi V; Postow MA; Tuck D; Wolchok JD
    Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifaceted role of autophagy in tumor evasion from immune surveillance.
    Janji B; Viry E; Moussay E; Paggetti J; Arakelian T; Mgrditchian T; Messai Y; Noman MZ; Van Moer K; Hasmim M; Mami-Chouaib F; Berchem G; Chouaib S
    Oncotarget; 2016 Apr; 7(14):17591-607. PubMed ID: 26910842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
    Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
    Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.